nimodipine has been researched along with Blood Pressure, High in 55 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study shows that nimodipine significantly reduces levels of blood pressure in patients with mild and moderate essential hypertension." | 9.06 | Effect of treatment with nimodipine in patients with mild and moderate essential hypertension. ( Dong, SM; Dong, XF; Lin, GZ; Liu, LS; Wang, SY; Wang, W; Xu, ZK; Yu, XH; Zhao, F, 1990) |
| "The current analysis shows that cerebral perfusion in the setting of secondary cerebral ischemia following SAH is measurably improved by milrinone and norepinephrine-based hyperdynamic therapy." | 8.12 | Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage. ( Andereggen, L; Berberat, J; Ensner, R; Marbacher, S; Remonda, L; Steiger, HJ, 2022) |
| "Bipolar disorder in pregnancy was treated with nimodipine, because of lithium-induced nephrogenic diabetes insipidus." | 7.71 | Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy. ( Mason, B; Utter, G; Vengalil, S; Yingling, DR, 2002) |
| "The efficacy and tolerability of the dihydropyridine calcium antagonist nimodipine (BAY e 9736) in the prophylaxis of ischemic neurological deficits after subarachnoid hemorrhage were investigated in 171 patients in an open, prospective, multicenter study." | 7.67 | Clinical experience with nimodipine in the prophylaxis of neurological deficits after subarachnoid hemorrhage. ( Adelt, D; Ammerer, HP; Baumann, H; Böker, DK; Grotenhuis, JA; Istaitih, AR; Jaksche, H; Karnick, R; Kazner, E; Sprung, C, 1985) |
| "Eighty-four patients were treated early with nimodipine intravenously, and thereafter orally, up to 21 days after aneurysmal subarachnoid hemorrhage." | 7.67 | Nimodipine treatment of selected good-risk patients with subarachnoid hemorrhage: no significant difference between present and historical results. ( Bolander, H; Carlsson, H; Pellettieri, L; Sjölander, U, 1988) |
| " The wafers were tested for their physical characteristics, ex vivo mucoadhesion strength, ex vivo mucoadhesion time, in vitro drug release, and in vitro permeation and in vivo bioavailability studies." | 5.36 | Development and evaluation of novel buccoadhesive wafers of nimodipine for treatment of hypertension. ( Ali, J; Ali, M; Hassan, N, 2010) |
| "Operative interventions in subarachnoid hemorrhages caused by brain vessel aneurysm require meticulous dissection of the latter." | 5.29 | [Controlled hypotension against a background of nimodipine during an operation on neurosurgical patients with hypertension]. ( Karadimov, D, 1995) |
| "Nimodipine is an effective vasodilator." | 5.29 | The haemodynamic and respiratory effects of intravenous nimodipine used in the treatment of eclampsia. ( Anthony, J; Dommisse, J; Johanson, R; Mantel, G, 1996) |
| " combined use of Jiangya Capsule (JYC) and Nimodipine (ND), on blood pressure, TCM clinical symptoms, and blood levels of vascular endothelial function and hypersensitive C-reactive protein (hs-CRP) in elderly patients with isolated systolic hypertension (EISH)." | 5.14 | [Effect of an integrative medical regimen on levels of vascular endothelial function and hypersensitive C-reactive protein in elderly patients with isolated systolic hypertension]. ( Han, YX; Li, H; Zhao, WM, 2009) |
| "200 primary hypertension patients were assigned to Xinmaitong group and Nimodipine group randomly." | 5.11 | [Clinical observation of the effect of xinmaitong tablet on hypertension]. ( Liang, B, 2005) |
| "An observational study based on the data from the Intravenous Nimodipine West European Stroke Trial (INWEST)." | 5.09 | High initial blood pressure after acute stroke is associated with poor functional outcome. ( Ahmed, N; Wahlgren, G, 2001) |
| "Possible drug interactions between the two calcium channel blockers nimodipine and nifedipine were investigated in 12 elderly patients with stable mild to moderate hypertension." | 5.08 | The influence of nimodipine on hemodynamic parameters and peak and trough plasma concentrations of nifedipine chronically administered to elderly hypertensive patients. ( Breuel, HP; Heine, PR; Kuhlmann, J; Mück, W; Niklaus, H; Schmage, N, 1995) |
| "This study shows that nimodipine significantly reduces levels of blood pressure in patients with mild and moderate essential hypertension." | 5.06 | Effect of treatment with nimodipine in patients with mild and moderate essential hypertension. ( Dong, SM; Dong, XF; Lin, GZ; Liu, LS; Wang, SY; Wang, W; Xu, ZK; Yu, XH; Zhao, F, 1990) |
| "The current analysis shows that cerebral perfusion in the setting of secondary cerebral ischemia following SAH is measurably improved by milrinone and norepinephrine-based hyperdynamic therapy." | 4.12 | Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage. ( Andereggen, L; Berberat, J; Ensner, R; Marbacher, S; Remonda, L; Steiger, HJ, 2022) |
| "Electron paramagnetic resonance (EPR) spectroscopy was used to investigate the gamma-radiation damage in the crystalline powder form of nine calcium channel blockers from the 1,4-dihydropyridine derivatives, which are in clinical use for treatment of arteria hypertension and ischemic heart disease." | 3.74 | The effect of ionizing radiation of 1,4-dihydropyridine derivatives in the solid state. ( Mielcarek, J; Naskrent, M, 2007) |
| "Bipolar disorder in pregnancy was treated with nimodipine, because of lithium-induced nephrogenic diabetes insipidus." | 3.71 | Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy. ( Mason, B; Utter, G; Vengalil, S; Yingling, DR, 2002) |
| "Eighty-four patients were treated early with nimodipine intravenously, and thereafter orally, up to 21 days after aneurysmal subarachnoid hemorrhage." | 3.67 | Nimodipine treatment of selected good-risk patients with subarachnoid hemorrhage: no significant difference between present and historical results. ( Bolander, H; Carlsson, H; Pellettieri, L; Sjölander, U, 1988) |
| "The efficacy and tolerability of the dihydropyridine calcium antagonist nimodipine (BAY e 9736) in the prophylaxis of ischemic neurological deficits after subarachnoid hemorrhage were investigated in 171 patients in an open, prospective, multicenter study." | 3.67 | Clinical experience with nimodipine in the prophylaxis of neurological deficits after subarachnoid hemorrhage. ( Adelt, D; Ammerer, HP; Baumann, H; Böker, DK; Grotenhuis, JA; Istaitih, AR; Jaksche, H; Karnick, R; Kazner, E; Sprung, C, 1985) |
| "Among these subtypes subcortical vascular dementia (SVD) may represent a well-defined entity in terms of pathophysiology, clinical features and neuroradiological aspects." | 2.71 | Therapy of vascular dementias. ( Basile, AM; Inzitari, D; Lamassa, M; Pantoni, L, 2004) |
| " An increasing dosage of nimodipine is accompanied by increasing cardiovascular effects." | 2.66 | [Hemodynamic effects in high-dose infusion of nimodipine, a new calcium antagonist]. ( Boldt, J; Hempelmann, G; Kling, D; Moosdorf, R; Ratthey, K; von Bormann, B, 1986) |
| "This process, known as cerebral vasospasm, is the most common cause of DCI after SAH." | 2.48 | Management of delayed cerebral ischemia after subarachnoid hemorrhage. ( Koenig, MA, 2012) |
| "She had a history of migraines and received methylergonovine at delivery." | 2.47 | A case of postpartum cerebral angiitis and review of the literature. ( Atlas, RO; Bakhru, A, 2011) |
| "Preeclampsia is associated with increased maternal and perinatal morbidity and mortality." | 2.41 | Management and monitoring of severe preeclampsia. ( Bolte, AC; Dekker, GA; van Geijn, HP, 2001) |
| " Earlier studies indicated that chronic administration of nimodipine revealed a protective effect in the occurrence of strokes in SHR-SP rats, yielding a decreased mortality rate." | 2.39 | Cerebrovascular, neuronal, and behavioral effects of long-term Ca2+ channel blockade in aging normotensive and hypertensive rat strains. ( de Jong, GI; Luiten, PG; Schuurman, T, 1994) |
| "For the treatment of hypertensive cerebral vasospasm, combined application of betahistine on the basis of nimodipine can effectively reduce the body's aseptic inflammatory responses, improve vascular endothelial function and increase the cerebral circulation blood flow, which offers a favorable strategy for clinical therapy." | 1.56 | Effects of nimodipine combined with betahistine on CRP and other inflammatory cytokines and vascular endothelial function in patients with hypertensive cerebral vasospasm. ( Liu, X; Luo, X; Sheng, P; Wang, Y; Xiao, P; Zeng, K; Zhao, N, 2020) |
| " We describe a patient with an apparent primary TCH, which repeatedly occurred immediately after micturition until she achieved a therapeutic dosage of nimodipine." | 1.37 | Thunderclap headache triggered by micturition: responsive to nimodipine. ( Gui, W; Han, YY; Liu, YM; Wang, K; Wang, Y; Zhu, J, 2011) |
| " The wafers were tested for their physical characteristics, ex vivo mucoadhesion strength, ex vivo mucoadhesion time, in vitro drug release, and in vitro permeation and in vivo bioavailability studies." | 1.36 | Development and evaluation of novel buccoadhesive wafers of nimodipine for treatment of hypertension. ( Ali, J; Ali, M; Hassan, N, 2010) |
| "Bathing headache is rarely described in literature." | 1.32 | Bathing headache: a variant of idiopathic thunderclap headache. ( Fuh, JL; Liao, YC; Lirng, JF; Lu, SR; Wang, SJ; Wu, ZA, 2003) |
| "Hypertension is the main cause of stroke that represents the second most common cause of death in the industrialized world and a leading cause of inability of the elderly." | 1.31 | Influence of treatment with Ca(2+) antagonists on cerebral vasculature of spontaneously hypertensive rats. ( Amenta, F; Sabbatini, M; Tomassoni, D, 2001) |
| "Hypertension is the main risk factor for cerebrovascular disease including vascular dementia and control of blood pressure might protect from lesions causing cognitive impairment." | 1.31 | Hypertensive brain damage: comparative evaluation of protective effect of treatment with dihydropyridine derivatives in spontaneously hypertensive rats. ( Amenta, F; Sabbatini, M; Tomassoni, D, 2001) |
| "Operative interventions in subarachnoid hemorrhages caused by brain vessel aneurysm require meticulous dissection of the latter." | 1.29 | [Controlled hypotension against a background of nimodipine during an operation on neurosurgical patients with hypertension]. ( Karadimov, D, 1995) |
| "Nimodipine is an effective vasodilator." | 1.29 | The haemodynamic and respiratory effects of intravenous nimodipine used in the treatment of eclampsia. ( Anthony, J; Dommisse, J; Johanson, R; Mantel, G, 1996) |
| "Nimodipine-treated as well as parathyroidectomied animals showed significantly fewer hypertensive cerebral lesions." | 1.28 | Therapy of diseased stroke-prone spontaneously hypertensive rats with nimodipine. ( Kazda, S; Lenz, P; Luckhaus, G; Stasch, JP, 1990) |
| "The nimodipine-treated animals, however, showed only a slight diminution in the slope of the curve but no real plateau, indicating impairment of CBF autoregulation." | 1.27 | The influence of nimodipine on cerebral blood flow autoregulation and blood-brain barrier. ( Gaab, MR; Höllerhage, HG; Walter, GF; Zumkeller, M, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (21.82) | 18.7374 |
| 1990's | 18 (32.73) | 18.2507 |
| 2000's | 16 (29.09) | 29.6817 |
| 2010's | 7 (12.73) | 24.3611 |
| 2020's | 2 (3.64) | 2.80 |
| Authors | Studies |
|---|---|
| Steiger, HJ | 1 |
| Ensner, R | 1 |
| Andereggen, L | 1 |
| Remonda, L | 1 |
| Berberat, J | 1 |
| Marbacher, S | 1 |
| Liu, X | 1 |
| Zhao, N | 1 |
| Zeng, K | 1 |
| Xiao, P | 1 |
| Sheng, P | 1 |
| Luo, X | 1 |
| Wang, Y | 2 |
| McIlroy, E | 1 |
| Sethuraman, R | 1 |
| Woograsingh, R | 1 |
| Nelson-Piercy, C | 1 |
| Gilbert-Kawai, E | 1 |
| Elstner, M | 1 |
| Linn, J | 1 |
| Müller-Schunk, S | 1 |
| Straube, A | 1 |
| Li, H | 1 |
| Zhao, WM | 1 |
| Han, YX | 1 |
| Hassan, N | 1 |
| Ali, M | 1 |
| Ali, J | 1 |
| Bakhru, A | 1 |
| Atlas, RO | 1 |
| Field, DK | 1 |
| Kleinig, TJ | 1 |
| Thompson, PD | 1 |
| Kimber, TE | 1 |
| Chatterjee, N | 1 |
| Domoto-Reilly, K | 1 |
| Fecci, PE | 1 |
| Schwamm, LH | 1 |
| Singhal, AB | 1 |
| Han, YY | 1 |
| Gui, W | 1 |
| Zhu, J | 1 |
| Liu, YM | 1 |
| Wang, K | 1 |
| Koenig, MA | 1 |
| Yingling, DR | 1 |
| Utter, G | 1 |
| Vengalil, S | 1 |
| Mason, B | 1 |
| Macdonald, RL | 1 |
| Rosengart, A | 1 |
| Huo, D | 1 |
| Karrison, T | 1 |
| Liao, YC | 1 |
| Fuh, JL | 1 |
| Lirng, JF | 1 |
| Lu, SR | 1 |
| Wu, ZA | 1 |
| Wang, SJ | 1 |
| Inzitari, D | 2 |
| Lamassa, M | 1 |
| Pantoni, L | 1 |
| Basile, AM | 1 |
| Liang, B | 1 |
| Poggesi, A | 1 |
| Naskrent, M | 1 |
| Mielcarek, J | 1 |
| Tavernier, B | 1 |
| Decamps, F | 1 |
| Vega, E | 1 |
| Poidevin, P | 1 |
| Verdin, M | 1 |
| Riegel, B | 1 |
| Kamath, S | 1 |
| Gadhinglajkar, SV | 1 |
| Engberding, R | 1 |
| Bender, F | 1 |
| Gülker, H | 1 |
| Specker, E | 1 |
| Molinski, M | 1 |
| Svendgaard, NA | 2 |
| Brismar, J | 2 |
| Delgado, T | 2 |
| Egund, N | 1 |
| Owman, C | 2 |
| Rodacki, MA | 1 |
| Sahlin, C | 2 |
| Salford, LG | 2 |
| Breuel, HP | 1 |
| Mück, W | 1 |
| Heine, PR | 1 |
| Schmage, N | 1 |
| Niklaus, H | 1 |
| Kuhlmann, J | 1 |
| Luiten, PG | 1 |
| de Jong, GI | 1 |
| Schuurman, T | 1 |
| Weir, B | 1 |
| MacDonald, L | 1 |
| Ueda, M | 1 |
| Masui, M | 1 |
| Kawakami, M | 1 |
| Matsunaga, K | 1 |
| Gemba, T | 1 |
| Ninomiya, M | 1 |
| Nakano, A | 1 |
| Torii, M | 1 |
| Adachi, I | 1 |
| Ito, H | 1 |
| Roine, RO | 1 |
| Anthony, J | 1 |
| Mantel, G | 1 |
| Johanson, R | 1 |
| Dommisse, J | 1 |
| Karadimov, D | 1 |
| Alekhin, MN | 1 |
| Sedov, VP | 1 |
| Botsina, GI | 1 |
| Sidorenko, BA | 1 |
| Nosenko, EM | 1 |
| Dennis, GC | 1 |
| Welch, B | 1 |
| Cole, AN | 1 |
| Mendoza, R | 1 |
| Morgan, J | 1 |
| Epps, J | 1 |
| Bernard, E | 1 |
| St Louis, P | 1 |
| Meneses, A | 2 |
| Terrón, JA | 1 |
| Ibarra, M | 1 |
| Hong, E | 2 |
| Morgan, MK | 1 |
| Sekhon, LH | 1 |
| Finfer, S | 1 |
| Grinnell, V | 1 |
| Bolte, AC | 1 |
| van Geijn, HP | 1 |
| Dekker, GA | 1 |
| Sabbatini, M | 2 |
| Tomassoni, D | 2 |
| Amenta, F | 2 |
| Ahmed, N | 1 |
| Wahlgren, G | 1 |
| Télez, M | 1 |
| Martínez, B | 1 |
| Criado, B | 1 |
| Ortega, B | 1 |
| Peñagarikano, O | 1 |
| Flores, P | 1 |
| Ortiz-Lastra, E | 1 |
| Arrieta, I | 1 |
| Boonen, HC | 1 |
| De Mey, JG | 1 |
| Brandt, L | 1 |
| Säveland, H | 1 |
| Romner, B | 1 |
| Ryman, T | 1 |
| Zhao, F | 2 |
| Hermsmeyer, K | 1 |
| Hatton, DA | 1 |
| Karanja, N | 1 |
| McCarron, D | 1 |
| Lenz, P | 1 |
| Luckhaus, G | 1 |
| Stasch, JP | 1 |
| Kazda, S | 1 |
| Wang, W | 3 |
| Yu, XH | 1 |
| Lin, GZ | 1 |
| Xu, ZK | 1 |
| Dong, SM | 1 |
| Dong, XF | 1 |
| Wang, SY | 1 |
| Liu, LS | 2 |
| Garthoff, B | 1 |
| Bellemann, P | 1 |
| Zhao, Y | 1 |
| Lei, YP | 1 |
| Zhang, XE | 1 |
| Jin, L | 1 |
| Thorén, P | 1 |
| Westling, H | 1 |
| Skarphedinsson, JO | 1 |
| Müller, H | 1 |
| Kafurke, H | 1 |
| Marck, P | 1 |
| Zierski, J | 1 |
| Hempelmann, G | 2 |
| Höllerhage, HG | 1 |
| Gaab, MR | 1 |
| Zumkeller, M | 1 |
| Walter, GF | 1 |
| Pellettieri, L | 1 |
| Bolander, H | 1 |
| Carlsson, H | 1 |
| Sjölander, U | 1 |
| Boldt, J | 1 |
| von Bormann, B | 1 |
| Kling, D | 1 |
| Ratthey, K | 1 |
| Moosdorf, R | 1 |
| Kazner, E | 1 |
| Sprung, C | 1 |
| Adelt, D | 1 |
| Ammerer, HP | 1 |
| Karnick, R | 1 |
| Baumann, H | 1 |
| Böker, DK | 1 |
| Grotenhuis, JA | 1 |
| Jaksche, H | 1 |
| Istaitih, AR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| MRI Evaluation of Nidus Occlusion After Gamma Knife Radiosurgery of Cerebral Arteriovenous Malformations - A Prospective Preliminary Study[NCT03995823] | 50 participants (Anticipated) | Observational | 2019-07-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for nimodipine and Blood Pressure, High
| Article | Year |
|---|---|
A case of postpartum cerebral angiitis and review of the literature.
Topics: Adult; Antihypertensive Agents; Cerebral Angiography; Female; Humans; Hypertension; Migraine Disorde | 2011 |
Management of delayed cerebral ischemia after subarachnoid hemorrhage.
Topics: Angioplasty, Balloon; Brain Ischemia; Calcium Channel Blockers; Cardiovascular Agents; Cerebral Angi | 2012 |
Calcium channel blockers and stroke.
Topics: Aged; Antihypertensive Agents; Atherosclerosis; Calcium Channel Blockers; Dementia, Vascular; Humans | 2005 |
Cerebrovascular, neuronal, and behavioral effects of long-term Ca2+ channel blockade in aging normotensive and hypertensive rat strains.
Topics: Aging; Animals; Behavior, Animal; Blood-Brain Barrier; Brain; Calcium; Calcium Channel Blockers; Cal | 1994 |
Cerebral vasospasm.
Topics: Aneurysm, Ruptured; Blood Pressure; Blood Volume; Brain Ischemia; Catheterization; Cerebral Infarcti | 1993 |
Management and monitoring of severe preeclampsia.
Topics: Adrenal Cortex Hormones; Antihypertensive Agents; Blood Pressure Determination; Female; Fetal Diseas | 2001 |
8 trials available for nimodipine and Blood Pressure, High
| Article | Year |
|---|---|
[Effect of an integrative medical regimen on levels of vascular endothelial function and hypersensitive C-reactive protein in elderly patients with isolated systolic hypertension].
Topics: Aged; C-Reactive Protein; Double-Blind Method; Drug Therapy, Combination; Drugs, Chinese Herbal; End | 2009 |
Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Huma | 2003 |
Therapy of vascular dementias.
Topics: Aged; Brain; Cognition Disorders; Dementia, Vascular; Double-Blind Method; Humans; Hypertension; Int | 2004 |
[Clinical observation of the effect of xinmaitong tablet on hypertension].
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Drug Combinations; Drugs, Chinese Herbal; Female; | 2005 |
The influence of nimodipine on hemodynamic parameters and peak and trough plasma concentrations of nifedipine chronically administered to elderly hypertensive patients.
Topics: Aged; Blood Pressure; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Drug Int | 1995 |
High initial blood pressure after acute stroke is associated with poor functional outcome.
Topics: Acute Disease; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Clinical Tri | 2001 |
Effect of treatment with nimodipine in patients with mild and moderate essential hypertension.
Topics: Adult; Aged; Humans; Hypertension; Middle Aged; Nimodipine | 1990 |
[Hemodynamic effects in high-dose infusion of nimodipine, a new calcium antagonist].
Topics: Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Hemodynamics; Humans; Hy | 1986 |
41 other studies available for nimodipine and Blood Pressure, High
| Article | Year |
|---|---|
Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Topics: Brain Ischemia; Cerebral Infarction; Hemodynamics; Humans; Hypertension; Milrinone; Nimodipine; Nore | 2022 |
Effects of nimodipine combined with betahistine on CRP and other inflammatory cytokines and vascular endothelial function in patients with hypertensive cerebral vasospasm.
Topics: Aged; Antihypertensive Agents; Betahistine; C-Reactive Protein; Cytokines; Female; Humans; Hypertens | 2020 |
Severe Postpartum Headache and Hypertension Caused by Reversible Cerebral Vasoconstriction Syndrome: A Case Report.
Topics: Adult; Anesthesia, Epidural; Brain Diseases; Female; Headache; Humans; Hypertension; Magnetic Resona | 2017 |
Reversible cerebral vasoconstriction syndrome: a complicated clinical course treated with intra-arterial application of nimodipine.
Topics: Brain; Cerebral Angiography; Female; Headache Disorders, Primary; Humans; Hyperlipidemias; Hypertens | 2009 |
Development and evaluation of novel buccoadhesive wafers of nimodipine for treatment of hypertension.
Topics: Acrylic Resins; Adhesiveness; Administration, Buccal; Animals; Antihypertensive Agents; Biological A | 2010 |
Reversible cerebral vasoconstriction, internal carotid artery dissection and renal artery stenosis.
Topics: Adult; Antihypertensive Agents; Brain; Carotid Artery, Internal, Dissection; Cerebrovascular Circula | 2010 |
Licorice-associated reversible cerebral vasoconstriction with PRES.
Topics: Administration, Oral; Brain; Cerebral Angiography; Cerebrovascular Circulation; Cerebrovascular Diso | 2010 |
Thunderclap headache triggered by micturition: responsive to nimodipine.
Topics: Antihypertensive Agents; Female; Headache Disorders, Primary; Humans; Hypertension; Middle Aged; Nim | 2011 |
Calcium channel blocker, nimodipine, for the treatment of bipolar disorder during pregnancy.
Topics: Adult; Bipolar Disorder; Calcium Channel Blockers; Diabetes Insipidus, Nephrogenic; Female; Gestatio | 2002 |
Bathing headache: a variant of idiopathic thunderclap headache.
Topics: Adult; Baths; Brain Infarction; Cerebellar Diseases; Cerebellum; Cerebral Arteries; Female; Headache | 2003 |
The effect of ionizing radiation of 1,4-dihydropyridine derivatives in the solid state.
Topics: Calcium Channel Blockers; Dihydropyridines; Electron Spin Resonance Spectroscopy; Felodipine; Gamma | 2007 |
[Systemic treatments of the vasospasm].
Topics: Hemodilution; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hy | 2007 |
Can changes in BIS provide clue to lower limit of cerebral autoregulation?
Topics: Adrenergic alpha-Agonists; Anesthesia, General; Antihypertensive Agents; Blood Pressure; Cerebrovasc | 2008 |
[Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure].
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Dose-Response Relationship, D | 1984 |
Late cerebral arterial spasm: the cerebrovascular response to hypercapnia, induced hypertension and the effect of nimodipine on blood flow autoregulation in experimental subarachnoid hemorrhage in primates.
Topics: Animals; Calcium Channel Blockers; Cerebral Angiography; Cerebrovascular Circulation; Electroencepha | 1983 |
Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 4th communication: prophylactic and therapeutic effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3- b]pyridine-5-carboxylate in stroke-prone spont
Topics: Animals; Behavior, Animal; Blood Pressure; Body Weight; Brain; Calcium Channel Blockers; Cerebrovasc | 1993 |
Nimodipine in patients with heart disease.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Cerebrovascular Disorders; Clinical Trials as Top | 1996 |
The haemodynamic and respiratory effects of intravenous nimodipine used in the treatment of eclampsia.
Topics: Adult; Blood Pressure; Eclampsia; Female; Hemodynamics; Humans; Hypertension; Infusions, Intravenous | 1996 |
[Controlled hypotension against a background of nimodipine during an operation on neurosurgical patients with hypertension].
Topics: Adolescent; Adult; Anesthesia, General; Antihypertensive Agents; Hemodynamics; Humans; Hypertension; | 1995 |
[Effect of nimodipine in the diastolic function of the left ventricle in patients with essential hypertension and atherosclerotic circulatory encephalopathy].
Topics: Administration, Oral; Aged; Calcium Channel Blockers; Diastole; Female; Hemodynamics; Humans; Hypert | 1996 |
Subarachnoid hemorrhage in the African-American population: a cooperative study.
Topics: Aminocaproates; Antifibrinolytic Agents; Black People; Brain Ischemia; Calcium Channel Blockers; Coh | 1997 |
Effects of nimodipine on learning in normotensive and spontaneously hypertensive rats.
Topics: Aging; Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Conditioning, Operant; Heart | 1997 |
Spontaneously hypertensive rats: a potential model to identify drugs for treatment of learning disorders.
Topics: Aging; Analysis of Variance; Animals; Blood Pressure; Calcium Channel Blockers; Cognition Disorders; | 1998 |
Delayed neurological deterioration following resection of arteriovenous malformations of the brain.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Aneurysm; Anticoagulants; Antihypertensive Agents; Asp | 1999 |
Influence of treatment with Ca(2+) antagonists on cerebral vasculature of spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Brain; Calcium Channel Blockers; Cerebrovascular C | 2001 |
Evaluation of the cytogenetic damage induced by the antihypertensive drug nimodipine in human lymphocytes.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cells, Cultured; Centromere; Female; Humans; Hyper | 2001 |
Hypertensive brain damage: comparative evaluation of protective effect of treatment with dihydropyridine derivatives in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Brain; Brain Injuries; Calcium Channel Blockers; D | 2001 |
Increased calcium sensitivity in isolated resistance arteries from spontaneously hypertensive rats: effects of dihydropyridines.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1990 |
Does nimodipine eliminate arterial hypertension as a prognostic risk factor in subarachnoid haemorrhage?
Topics: Adolescent; Adult; Aged; Female; Humans; Hypertension; Intracranial Aneurysm; Ischemic Attack, Trans | 1991 |
[Clinical studies on the improvement of failing memory by nimodipine].
Topics: Epinephrine; Female; Humans; Hypertension; Male; Memory Disorders; Middle Aged; Neuropsychological T | 1990 |
Effects of dietary calcium on nimodipine-sensitive calcium channel function in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Calcium Channels; Calcium, Dietary; Cells, Cultured; Cerebrovascular Disord | 1990 |
Therapy of diseased stroke-prone spontaneously hypertensive rats with nimodipine.
Topics: Aging; Animals; Brain; Calcium; Cerebrovascular Disorders; Creatinine; Hypertension; Kidney; Male; M | 1990 |
Effects of salt loading and nitrendipine on dihydropyridine receptors in hypertensive rats.
Topics: Animals; Blood Pressure; Brain; Calcium Channel Blockers; Calcium Channels; Hypertension; Membranes; | 1987 |
Calcium antagonists in prevention of hypertension and stroke in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Calcium Channel Blockers; Cerebrovascular Disorders; Female; Hypertension; Male; Nifedipine | 1989 |
[Effects of nimodipine on blood pressure and cardiac function in hypertensive patients].
Topics: Adult; Aged; Blood Pressure; Female; Heart; Humans; Hypertension; Male; Middle Aged; Nimodipine; Ran | 1989 |
Effect of the calcium antagonists felodipine and nimodipine on cortical blood flow in the spontaneously hypertensive rat.
Topics: Animals; Blood Pressure; Cerebral Cortex; Felodipine; Homeostasis; Hydrogen; Hypertension; Male; Nim | 1989 |
Interactions between nimodipine and general anaesthesia--clinical investigations in 124 patients during neurosurgical operations.
Topics: Anesthesia, General; Anesthesia, Inhalation; Anesthetics; Blood Pressure; Drug Interactions; Humans; | 1988 |
The influence of nimodipine on cerebral blood flow autoregulation and blood-brain barrier.
Topics: Animals; Blood Pressure; Blood-Brain Barrier; Cerebrovascular Circulation; Electrodes; Evans Blue; H | 1988 |
Nimodipine treatment of selected good-risk patients with subarachnoid hemorrhage: no significant difference between present and historical results.
Topics: Adolescent; Adult; Brain Ischemia; Child; Child, Preschool; Follow-Up Studies; Humans; Hypertension; | 1988 |
Cerebrovascular and metabolic changes during the delayed vasospasm following experimental subarachnoid hemorrhage in baboons, and treatment with a calcium antagonist.
Topics: Animals; Blood Flow Velocity; Cerebral Angiography; Cerebral Arteries; Disease Models, Animal; Femal | 1987 |
Clinical experience with nimodipine in the prophylaxis of neurological deficits after subarachnoid hemorrhage.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Female; Heart Rate; Humans; Hypertension; Intracran | 1985 |